Immunization status of patients with spinal muscular atrophy receiving nusinersen therapy.

Yesilmen, Mehmet Can; Günay, Çagatay; Sarikaya Uzan, Gamze; Özsoy, Özlem; Hiz Kurul, Semra; Yis, Uluç

Yesilmen, Mehmet Can; Günay, Çagatay; Sarikaya Uzan, Gamze; Özsoy, Özlem; Hiz Kurul, Semra; Yis, Uluç.

Afiliação

Yesilmen MC; Department of Pediatric Neurology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey. Electronic address: mcanyesilmen@gmail.com.
Günay Ç; Department of Pediatric Neurology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey.
Sarikaya Uzan G; Department of Pediatric Neurology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey.
Özsoy Ö; Department of Pediatric Neurology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey.
Hiz Kurul S; Department of Pediatric Neurology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey.
Yis U; Department of Pediatric Neurology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey.

Arch Pediatr ; 30(5): 291-296, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37147157

Assuntos

Vacinas contra Influenza; Influenza Humana; Atrofia Muscular Espinal; Atrofias Musculares Espinais da Infância; Humanos; Criança; Estudos Prospectivos; Estudos Transversais; Vacina BCG/uso terapêutico; Vacinação; Vacinas Pneumocócicas

Palavras-chave

Immunization; Influenza; Nusinersen; Spinal muscular atrophy; Vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atrofia Muscular Espinal / Vacinas contra Influenza / Atrofias Musculares Espinais da Infância / Influenza Humana Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google